Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. The recent approval of albuterol/budesonide could change the way that mild asthma is treated in ...

Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...

Please provide your email address to receive an email when new articles are posted on . Risk and annualized rate of severe exacerbations dropped with as-needed use of albuterol-budesonide vs.

As-needed fixed-dose albuterol–budesonide may lower the risk of severe asthma exacerbations, as compared with as-needed albuterol alone, in patients with uncontrolled disease despite treatment for ...

Teva Pharmaceuticals lost its patent row with Amneal Pharmaceuticals on Monday as a New Jersey court ruled that some of Teva’s claims over its inhaler product ProAir HFA were improperly listed on the ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration (“FDA”) has granted approval for the Company ...

Low dose chemotherapy involves smaller doses of medications that are given more often than the doses in traditional higher dose regimens. Learn about the advantages and effectiveness of each approach.

Stiolto Respimat (tiotropium bromide/olodaterol) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). It comes with an inhaler for breathing the drug into your ...

Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...

Mestinon (pyridostigmine bromide) is a brand-name drug that’s prescribed for myasthenia gravis. Mestinon comes as an oral tablet, extended-release oral tablet, and oral solution. The dosage can vary ...